| Authors: |
Boult JK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. jessica.boult@icr.ac.uk., Borri M; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK., Jury A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Popov S; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Box G; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Perryman L; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Eccles SA; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Jones C; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Robinson SP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. |